Features

New Data Underscore Importance of Looking for HCM Before Scheduling TAVR

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

Board Certification Brouhaha: Rads Cry Foul Over ABR’s Ways and Means

At the American College of Radiology’s 2019 meeting last May, speaker after speaker stepped up to the open microphone in the ballroom of a Washington, D.C., hotel to vent their displeasure with the American Board of Radiology (ABR) and its maintenance of certification (MOC) program.

COVID or Not, Big Money is Buying Radiology Practices. Should Yours Be Selling?

Ahead of print in Radiology Business Journal: As private medical practices continue feeling the squeeze of consolidation across U.S. healthcare, many radiology groups are considering acquisition offers from physician practice management companies (PPMCs).

Seeing the Future–in 3D: New CPT Codes Set the Stage for Expanding 3D Printing in Cardiology

Until recently, cardiologists’ eyes tended to glaze over at the mention of using 3D printing in their practices. Most believed the costs would be too high for routine use, that the applications and the price tag were better suited to academic applications.

Data Dilemma: Taming Healthcare’s Beautiful Beast

To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.

90 Days a Dyad (or Triad): Strategies for Success & Errors to Avoid in the Crucial Early Days of Partnership

Experienced dyad and triad partners share tips for setting the stage for success and putting the brakes on mistakes.

New Take on Transplant: Reconsidering Hepatitis C-infected Hearts for Donation

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.

Pop Goes the Pillbox: Will Polypharmacy Problems Limit the Adoption of SGLT2 Inhibitors?

Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?

Tackling the Undertreatment of Aortic Stenosis in the U.S.

The problem is fixable, but it will take hard work, says one Duke University researcher. And cardiologists could be the key.

Transcarotid Access: The Future of Non-femoral TAVR?

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

As Surgery Gives Way to Transcatheter Procedures, Is the Cardiology Cash Cow in Jeopardy?

With minimally invasive structural procedures crowding out their surgical counterparts, how are physicians and hospitals preparing for the new reality?

FDA Expands Indication for TAVR to Low-risk Patients

The U.S. now will allow TAVR for patients at low risk for death or major complications during open-heart surgery.

Around the web

Cardiovascular Business

New TAVR valve from MiRus linked to positive early outcomes

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.

Cardiovascular Business

EHR-driven PCI risk assessments could make a world of difference

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients.

Cardiovascular Business

FDA expands approval of Boston Scientific’s Farapulse PFA system

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.